SK Inc. affiliate SK Pharmteco aims to become a top global CDMO with $2B in annual sales

SK Inc. and ION Clean Energy Enter New Partnership to Commercialize ION’s Industry-Leading Carbon Capture Technology

SK Inc. and SK Materials Merge to Strengthen its High-tech Materials Business

SK Inc. becomes second-largest shareholder of the Center for Breakthrough Medicines, a U.S.-based Cell and Gene Therapy (CGT) CDMO, accelerating its growth as a global leader in the field

SK Inc. Biopharm Investment and Sister Company Sign Collaborations to Advance Promising Area of Drug Development

SK Inc. Invests in Fulcrum BioEnergy to Accelerate Production of Low-Carbon Fuel from Waste

SK Inc. Invests in Monolith Materials, a U.S. Producer of Green Hydrogen and Green Solid Carbon

SK Inc. Launches Dedicated Hydrogen Business to Significantly Grow Output

SK Inc. Leads Investment in Monolith Materials to Accelerate Green Energy Growth

SK Inc. Materials Initiates Blue Ammonia Business with ExxonMobil

SK Inc. Receives the Highest ESG Rating of ‘AAA’ from MSCI

SK Inc. Showcases Sustainable Food, K-Bingsu, at CES 2023

SK Inc. Signs MOU with Monolith to Collaborate on Clean Hydrogen and Eco-friendly Carbon Black Products in South Korea